Bioinformatic development of a recombinant trivalent synthetic protein construct using PTXa, Tox, and TetX toxins as a DTP vaccine candidate

Publish Year: 1403
نوع سند: مقاله ژورنالی
زبان: English
View: 9

This Paper With 12 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_ARCHRAZI-79-4_013

تاریخ نمایه سازی: 15 شهریور 1403

Abstract:

Traditionally, diphtheria-tetanus-pertussis (DTwP or DTaP) as pediatric vaccines are produced from the corresponding inactivated toxins or whole cell pathogenic bacteria of Corynebacterium diphtheria toxin (Tox), Clostridium tetani toxin (TetX) and Bordetella pertussis. There are major concerns in the classic or acellular DTP (DTaP) vaccine production processes from native live sources of bacteria as it may raise concerns on adverse effects and safety issues, complexity of the purifications for each agent as well as costs. Here, we designated recombinant multi-epitope candidate vaccine by vaccino-informatics study to address mentioned issues and to develop a single trivalent fusion protein as potent recombinant DTP vaccine. To follow these goals, stages of immune-bioinformatics were retrieved by means of proteinaceous toxins sequences, predicting secondary/tertiary structure and transmembrane topology, energy minimization and models validation. Then, conformational and linear B cell epitope prediction by several different servers, mapping consensus linear/discontinuous immunogenic regions and constructing synthetic fusion vaccine candidate in respect to optimal immunogenic, physico-chemical properties and highly expression in prokaryote host were achieved. Finally, reverse translation, codon optimization, addition of cloning tags for pet ۲۸a vector and optimizations of physico-chemical characteristics of synthetic trivalent fusion protein were performed. By different hybrid immune-informatics and structural bioinformatics analysis predicted and experimental epitopes finally, ۱۲ new consensus highly immunogenic linear and discontinuous epitopes in Tox, TetX and PTXa proteins were selected. Peptide sequence of these immunogenic regions were as follow; PTXA (AA۳۴-۶۴, AA۱۸۴-۲۵۶ and AA۹۸-۱۱۶), Tox (AA۴۷-۷۶, AA۱۱۷-۱۵۹, AA۵۱۵-۵۵۷ and AA۲۴۵-۲۶۵) and TetX (AA۲۲۶-۲۴۹, AA۸۱۹-۸۴۴, AA۹۲۳-۹۶۷, AA۱۰۰۹-۱۰۶۷ and AA۱۲۲۵-۱۳۱۵). Moreover, the characteristics of recombinant trivalent fusion construct were; ۵۴۶ residue length, solvable (Grand average of hydropathicity (GRAVY) was -۰.۴۷۵), estimated half-life was >۱۰ hours in Escherichia coli, pI ۵.۹۴ (a little acidic), stable protein (The instability index (II) ۳۵.۵۸) as well as thermal stable (Aliphatic index (AI) ۷۱.۶۷). The putative antigenic epitopes from different organisms in a single protein, as in the current study, possibly will improve the protective effectiveness as novel potent, safe, cheap and broad-spectrum vaccines for better prevention of diphtheria, tetanus and pertussis infections in future.

Authors

zahra salahi

Department of Microbiology, Faculty of Medicine, Shahed University, Tehran, Iran.

Mojtaba Nofeli

Razi Vaccine and Serum Research Institute (RVSRI), Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.

Mohammad mehdi Ranjbar

Razi Vaccine and Serum Research Institute (RVSRI), Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.

Masoumeh Bagheri

Razi Vaccine and Serum Research Institute (RVSRI), Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.

Majid Esmaelizad

Razi Vaccine and Serum Research Institute (RVSRI), Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.

Mohammad Niakan

Department of Microbiology, Faculty of Medicine, Shahed University, Tehran, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Ogden SA, Ludlow JT, Alsayouri K. Diphtheria Tetanus Pertussis (DTaP) ...
  • Prygiel M, Mosiej E, Górska P, Zasada AA. Diphtheria-tetanus-pertussis vaccine: ...
  • Liang JL, Tiwari T, Moro P, Messonnier NE, Reingold A, ...
  • Howe BJ. Diphtheria-tetanus-acellular pertussis (DTaP) vaccine. JAMA. ۱۹۹۶;۲۷۶(۲۲):۱۸۰۳-۴ ...
  • Cherry JD. Comparative efficacy of acellular pertussis vaccines: an analysis ...
  • Aminian M, Sivam S, Lee CW , Halperin SA , Lee SF. Expression and ...
  • boucher Ph, stato H, satot,lotchi C. Neutralizing Antibodies and Immunoprotection ...
  • Torkashvand A, Bahrami.F, Adib. M, Ajdary S. Subcutaneous administration of ...
  • Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, ...
  • Studer, G., Rempfer, C., Waterhouse, A.M., Gumienny, R., Haas, J., ...
  • Benkert, P., Biasini, M., Schwede, T. Toward the estimation of ...
  • Rinaudo CD, Telford JL, Rappuoli R, Seib KL J. Vaccinology ...
  • Capecchi B, Serruto D, Adu-Bobie J, Rappuoli R, Pizza M. ...
  • Ansari HR, Gajendra Ps Raghava. Identification of conformational B-cell Epitopes ...
  • Kolaskar AS, Tongaonkar PS. A semi-empirical method for prediction of ...
  • Grote A, Hiller K, Scheer M, Münch R, Nörtemann B, ...
  • Zarei S, Akhondi M, Zamani A.H, Zeraati H, Bonakdar S, ...
  • arami M, Ameri P, Bathaei J. et al. Adverse events ...
  • Ranjbar M, Ebrahimi M, Shahsavandi S, Farhadi T, Mirjalili A, ...
  • Bahadori Z, Shafaghi M, Sabzevari J, Madanchi H, Ranjbar MM, ...
  • Ruth E. Soria et al. Oral immunogenicity of tomato-derived sDPT ...
  • Rawat SS, Keshri AK, Kaur R, Prasad A. Immunoinformatics Approaches ...
  • نمایش کامل مراجع